KCM
MEDP icon

Kendall Capital Management’s Medpace MEDP Stock Holding History

Kendall Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
2,280
-20
-0.9% -$9.23K 0.2% 118
2026
Q1 		$1.1M Sell
2,300
-155
-6% -$79.4K 0.23% 112
2025
Q4 		$1.38M Sell
2,455
-245
-9% -$139K 0.29% 89
2025
Q3 		$1.39M Sell
2,700
-155
-5% -$67.7K 0.31% 75
2025
Q2 		$896K Sell
2,855
-60
-2% -$18K 0.24% 106
2025
Q1 		$888K Sell
2,915
-50
-2% -$16.8K 0.26% 104
2024
Q4 		$985K Sell
2,965
-155
-5% -$52.6K 0.29% 89
2024
Q3 		$1.04M Sell
3,120
-95
-3% -$36.1K 0.32% 84
2024
Q2 		$1.32M Sell
3,215
-225
-7% -$89.1K 0.44% 66
2024
Q1 		$1.39M Sell
3,440
-111
-3% -$39K 0.48% 65
2023
Q4 		$1.09M Sell
3,551
-199
-5% -$53.7K 0.42% 76
2023
Q3 		$908K Sell
3,750
-670
-15% -$171K 0.4% 77
2023
Q2 		$1.06M Hold
4,420
– – 0.47% 75
2023
Q1 		$831K Hold
4,420
– – 0.4% 83
2022
Q4 		$939K Sell
4,420
-25
-0.6% -$5K 0.47% 69
2022
Q3 		$699K Hold
4,445
– – 0.41% 78
2022
Q2 		$665K Hold
4,445
– – 0.37% 87
2022
Q1 		$727K Hold
4,445
– – 0.35% 90
2021
Q4 		$967K Sell
4,445
-355
-7% -$74.3K 0.46% 74
2021
Q3 		$909K Sell
4,800
-200
-4% -$36.5K 0.49% 67
2021
Q2 		$883K Sell
5,000
-250
-5% -$43.1K 0.5% 64
2021
Q1 		$861K Buy
5,250
+190
+4% +$29.1K 0.53% 62
2020
Q4 		$704K Sell
5,060
-5
-0.1% -$630 0.51% 64
2020
Q3 		$566K Buy
5,065
+620
+14% +$71.7K 0.49% 65
2020
Q2 		$413K Buy
4,445
+1,410
+46% +$120K 0.4% 73
2020
Q1 		$223K Buy
+3,035
New +$263K 0.25% 93

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Kendall Capital Management's MEDP Position: Q2 2026 in Review

Kendall Capital Management reduced its Medpace (MEDP) stake by 0.87% in Q2 2026, selling an estimated $9.23K and leaving 2,280 shares worth $1.21M. The position accounts for 0.2% of the portfolio, ranked #118.

Kendall Capital Management first reported a position in MEDP in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.39M in Q1 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kendall Capital Management held 2,280 shares of Medpace worth $1.21M as of Q2 2026.
  • Kendall Capital Management sold 20 Medpace shares in Q2 2026, an estimated $9.23K.
  • Medpace made up 0.2% of Kendall Capital Management's portfolio in Q2 2026, its #118 holding.
  • Kendall Capital Management first reported a position in Medpace in Q1 2020 and has held it in 26 quarters since.
  • Kendall Capital Management's Medpace position peaked at $1.39M in Q1 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.